Immuneering IMRX
NASDAQ IMRX
$4.16 +0.03 (+0.61%)
As of: Sep 30, 2026 · 12:58 PM EDT

Immuneering Corp (IMRX) EBT Margin (2020 - 2022)

Updated

Immuneering's EBT Margin was -2960184.40% in Q4 2022, down 2954396.74 percentage points from -5787.65% a year earlier and down 2926403.35 percentage points from the prior quarter.

Analysis

Immuneering Corp (IMRX) EBT Margin (2020 - 2022) Analysis & Trends

For FY2022, EBT Margin at Immuneering came in at -15937.29%, down 14310.18 percentage points from FY2021.

  • In earlier years, EBT Margin was -1627.11% in FY2021 (-889.94 pp) and -737.17% in FY2020.
  • The Q4 2022 figure marks the lowest quarterly EBT Margin in data going back to Q2 2020.
  • Compared with a year earlier, EBT Margin has declined for seven straight quarters, with an average year-over-year change of -430001.25 percentage points over the last seven quarters.
  • Per Business Quant data, IMRX's EBT Margin in the three quarters before Q4 2022 was -33781.04% (Q3 2022), -12183.19% (Q2 2022) and -6964.23% (Q1 2022).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -2,960,184.40%
Sep 30, 2022 -33,781.04%
Jun 30, 2022 -12,183.19%
Mar 31, 2022 -6,964.23%
Dec 31, 2021 -5,787.65%
Sep 30, 2021 -1,768.40%
Jun 30, 2021 -1,210.18%
Mar 31, 2021 -832.62%
Dec 31, 2020 -877.48%
Sep 30, 2020 -644.49%
Jun 30, 2020 -749.56%
API Access

Immuneering Corp EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=IMRX&period=max&api_key=YOUR_API_KEY